education
Download App
Indonesia
search
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Download App
Country
Indonesia
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Iklan
Iklan
MIMS home
Drugs
Info
Linesti
Linesti
lidocaine
Manufacturer:
Konimex
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Contents
Lidocaine HCl monohydrate
Indications/Uses
Local or regional anesth.
Dosage/Direction for Use
Adult
Infiltration procedure
200 mg.
Epidural anesth
100-200 mg.
Contraindications
Hypersensitivity. Hypotension or coagulation disorder, patients receiving anticoagulation therapy. Inflammation &/or sepsis on inj site.
Special Precautions
Patients w/ epilepsy, heart conduction disorder, bradycardia, severe shock or digitalis intoxication. Elderly.
Adverse Reactions
CNS manifestations eg, dizziness, anxiety, euphoria, confusion, tinnitus, hyperacoustic, blurred vision, vomiting; CV symptoms eg, bradycardia, hypotension, allergic reaction, neurological symptoms eg, persistent numbness, paresthesia.
View
ADR Reporting Link
Drug Interactions
Antiarrhythmic agents, amiodarone, β-adrenoreceptor antagonist, cimetidine, anticonvulsants, inhaled anesth, muscle relaxants.
MIMS Class
Anaesthetics - Local & General
ATC Classification
N01BB02 - lidocaine ; Belongs to the class of amides. Used as local anesthetics.
Regulatory Classification
K
Presentation/Packing
Form
Linesti inj 20 mg/mL
Packing/Price
2 mL x 5 × 1's
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk